Pulmonary Cell News Volume 15.01 | Jan 26 2026

    0
    49







    2026-01-29 | PULCN 15.01


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 15.01 – 29 January, 2026

    TOP STORY

    Aberrant Cellular Communities Underlying Disease Heterogeneity in Chronic Obstructive Pulmonary Disease

    Researchers profiled lung tissue by single-nucleus RNA sequencing from 141 study participants and identified shifts in cell composition and emergent cell states to investigate chronic obstructive pulmonary disease heterogeneity.
    [Nature Genetics]

    Full Article
    Download these free lab templates to increase your efficiency as a life science researcher.
    PUBLICATIONSListed by the impact factor of the journal

    Single-Cell Atlas of Human Lung Aging Identifies Cell Type Dyssynchrony and Increased Transcriptional Entropy

    Investigators characterized the changing cellular, transcriptional, and genomic landscape of human lung aging using single-cell RNA sequencing.
    [Nature Communications]

    Abstract

    Calumenin Prevents Fibroblast Senescence and Lung Aging by Promoting Vimentin Proteostasis

    To investigate the alterations in fibroblasts, particularly the molecular programs driving this profibrotic evolution in the aging lung, scientists isolated senescent lung fibroblasts from aged mice.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Synergistic Regulation of TGF-β1/Smad2/3 Signaling and Inflammatory Pathways via SA/NAC-Based Nanoplatforms: A Novel Strategy to Enhance Anti-Fibrotic Therapeutic Outcomes in Idiopathic Pulmonary Fibrosis

    The authors demonstrated that macrophage-derived apoptotic body delivery system co-loaded with sodium arsenite (SA) and N-acetylcysteine (NAC) represents an effective therapeutic strategy for idiopathic pulmonary fibrosis.
    [Journal of Nanobiotechnology]

    Abstract

    Histone Demethylase KDM7A Negatively Regulates Fibrotic Macrophage Polarization and Lung Fibrosis Progression

    Researchers uncovered an epigenetic mechanism restraining disease-driving macrophage states and suggested the lysine-specific demethylase 7 A (KDM7A)-toll-like receptor 8 axis as a potential therapeutic target in fibrotic disorders.
    [Communications Biology]

    AbstractGraphical Abstract

    SULT1E1 Exerts a Protective Role in COPD by Inhibiting the AKT Pathway: An In Vivo and In Vitro Study

    Investigators aimed to assess estrogen sulfotransferase (SULT1E1) expression and underlying mechanisms in chronic obstructive pulmonary disease (COPD) pathogenesis.
    [Scientific Reports]

    Full Article

    Oncogenic p53 Induces Mitotic Errors in Lung Cancer Cells by Recopying DNA Replication Forks Conferring Targetable Proliferation Advantage

    Researchers revealed a novel mechanism which interconnects replication stress induced by oncogenic p53 to its stabilization and ability to generate chromosomal aberration in lung cancer cells that both accelerate tumor growth and serve as a targetable therapeutic vulnerability.
    [Cell Death & Disease]

    Full ArticleGraphical Abstract

    EGFR-Mutant Transformed Small Cell Lung Cancer Harbors Intratumoral Heterogeneity Targetable with MEK Inhibitor Combination Therapy

    Investigators demonstrated that EGFR-mutant SCLC is composed of mixed cell states with distinct therapeutic vulnerabilities and offer a therapeutic strategy to target tumor heterogeneity in highly plastic and treatment-resistant malignancies.
    [JCI Insight]

    Full Article

    The Prognostic Value of miR-323b-5p in Non-Small Cell Lung Cancer and Its Mechanism of Targeting IL1A in Regulating the Proliferation and Cell Cycle of Non-Small Cell Lung Cancer Cells

    Scientists investigated the expression and prognostic value of miR-323b-5p in NSCLC patients, and to clarify the mechanisms of miR-323b-5p and interleukin 1α (IL1A) on the proliferation and cell cycle of NSCLC cells.
    [Discover Oncology]

    Abstract
    Generate Consistent Airway Organoids With PneumaCultâ„¢
    REVIEWS

    Genetic and Molecular Mechanisms in Lung Cancer with Interstitial Pneumonia

    The authors summarize the current molecular insights into lung carcinogenesis in lung cancer with idiopathic pulmonary fibrosis and present findings from recent comprehensive genetic analysis.
    [International Journal of Clinical Oncology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Summit Therapeutics Announces US FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy

    Summit Therapeutics, Inc. announced that the FDA has accepted for filing Summit’s BLA seeking approval for ivonescimab in combination with chemotherapy in patients with epidermal growth factor receptor-mutated locally advanced or metastatic non-squamous NSCLC post-tyrosine kinase inhibitor (TKI) therapy.
    [Summit Therapeutics, Inc.]

    Press Release
    FEATURED EVENT

    4th Epithelial Mesenchymal Interactions in Lung Development & Fibrosis Conference

    March 7-10, 2026
    Playa Mujeres, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Associate – Tissue Regeneration

    University of Illinois at Chicago – Chicago, Illinois, United States

    Instructor and Assistant Professor Faculty – Perioperative Medicine and Critical Care

    University of Texas Health Science Center – Houston, Texas, United States

    Assistant or Associate Professor – Inflammation and Lung Research

    Temple University – Philadelphia, Pennsylvania, United States

    Researcher – Interstitial Lung Diseases and Autoimmunity

    INSERM – Rennes, France

    Postdoctoral Research Associate – Lung and Mammary Gland

    Princeton University – Princeton, New Jersey, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2